ANI Pharmaceuticals Inc (ANIP)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	18,779	-47,896	-42,603	-22,548	6,094
Revenue	US$ in thousands	454,334	287,962	202,731	198,984	206,547
Net profit margin		4.13%	-16.63%	-21.01%	-11.33%	2.95%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $18,779K ÷ $454,334K
= 4.13%

The net profit margin of ANI Pharmaceuticals Inc has shown fluctuations over the past five years. In 2019, the company achieved a net profit margin of 2.90%, indicating that for every dollar of revenue generated, the company retained $0.029 as profit. However, in the subsequent years, the net profit margins were negative, with a significant decrease in 2021, where the net profit margin stood at -19.80%. This negative figure suggests that the company incurred more expenses than it earned in revenue during that period.

The net profit margin improved in 2022 to -15.65%, although still negative, indicating a relatively better financial performance compared to 2021. In the most recent year, 2023, ANI Pharmaceuticals Inc managed to turn its performance around, achieving a positive net profit margin of 3.52%. This improvement signifies that the company was able to generate profit relative to its revenue in 2023.

Overall, the fluctuating trend in net profit margins reflects the company's varying ability to control costs, manage expenses, and generate profits over the analyzed period. The positive net profit margin in 2023 indicates a potentially healthier financial position for ANI Pharmaceuticals Inc compared to the preceding years.